TNFRSF17 and systemic lupus erythematosus: Therefore, we speculate that TNFRSF17 plays a pathogenic role in both PBMCs and local kidney tissue of LN patients, and further investigation into the possibility of targeting TNFRSF17 for the treatment of lupus is warranted.